In vivo gene disruption and homology-directed repair in muscles and muscle stem cells using CRISPR/Cas9
This study utilizes an AAV-delivered reporter system to demonstrate that CRISPR/Cas9-mediated homology-directed repair occurs at varying rates across postnatal cardiac and skeletal muscles and their stem cells depending on developmental timing, ultimately enabling the successful rescue of the dystrophin mutation in mdx mice.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside every living cell, the DNA acts as a master blueprint, holding the instructions for building and maintaining an organism. Sometimes, errors creep into these instructions, leading to diseases that affect how muscles work or how the heart beats. Scientists have developed a powerful tool called CRISPR/Cas9, which functions like a pair of molecular scissors. This tool can find a specific spot in the DNA and make a clean cut. Once the cut is made, the cell's natural repair machinery kicks in to fix the break. There are two main ways the cell handles this repair. One method is quick and messy, often leaving the DNA slightly damaged or altered, which can disable a faulty gene. The other method is precise and careful; it uses a provided template to copy the correct sequence over the broken spot, effectively rewriting the error into the right instruction. This second method, known as homology-directed repair, is the holy grail for curing genetic diseases because it can restore the original, healthy code. However, for a long time, scientists believed that while this precise repair worked well in some tissues, it simply did not happen in skeletal muscle, the tissue that moves our limbs.
A team of researchers set out to test whether this belief was true and to understand how the timing of a mouse's life affects the ability of its muscles to perform this precise repair. They used a special virus, which acts as a delivery vehicle, to carry the gene-editing tools into the bodies of living mice. To see exactly what happened inside the cells, they engineered a system where a gene that normally glows green would be cut and replaced with a gene that glows blue, but only if the precise repair method worked. This allowed them to track the success of the editing in real time, distinguishing between cells that simply had a broken gene and those that had been perfectly corrected. They examined the hearts and skeletal muscles of mice at different ages, from newborns to juveniles, to see if the age of the animal changed the outcome.
The results showed that the ability to perform this precise repair is not a fixed trait but depends heavily on both the type of tissue and the developmental stage of the animal. In the hearts of newborn mice, the precise repair happened with high efficiency. In contrast, the skeletal muscles of these same newborns were much less successful at this task. However, as the mice grew older, the situation reversed. In juvenile mice, the skeletal muscle stem cells—the tiny reservoirs that help repair and grow muscle tissue—readily underwent the precise repair, as did the mature muscle fibers themselves. The researchers found that the heart tissue in these older mice became less efficient at the precise repair compared to the newborns. This revealed that the window for successful gene correction shifts as an animal develops, with different tissues becoming more or less receptive at different times.
To prove that this approach could fix a real disease, the team applied their method to mice with a specific genetic defect that causes a form of muscular dystrophy. This condition is caused by a mutation that prevents the production of a vital muscle protein. By delivering the editing tools and a correct template to these mice, the researchers successfully guided the muscle cells to use the precise repair method. They observed that the cells in both the skeletal muscles and the heart switched from producing the broken protein to producing the healthy, wild-type version. This demonstrated that the precise rewriting of the genetic code was not just a theoretical possibility but a functional reality in living animals. The study confirms that while the rules of gene repair vary across tissues and ages, the potential to correct genetic errors in muscle and heart tissue is real, provided the right timing and conditions are met. These findings offer a clearer path for developing therapies that rely on precise gene correction, showing that the body's own repair mechanisms can be guided to fix the root causes of muscle disease.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.